The HDAC inhibitors givinostat (ITF2357), suberoylanilide hydroxamic acid (SAHA), and trichostatin-A have been shown to inhibit joint swelling and cell influx in several different animal models of arthritis [32–34]. This evidence concerns the gene HDAC9 and arthritic joint disease.